Modified National Early Warning Score 2, a reliable early warning system for predicting treatment outcomes in patients with emphysematous pyelonephritis

Table 3 Demographic data of emphysematous pyelonephritis patients in our study, n (%)

Pt characteristics	Group 1: Score 0-6 (n = 83)	Group 2: Score 7-14 (n = 76)	Group 3: Score 15-20 (n = 12)	P value
Mean age in years (SD)	52.639 (10.55)	55.553 (11.95)	60.083 (3.45)	0.046
Age > 50 years				0.053
Yes	56 (67.47)	57 (75)	12 (100)
No	27 (32.53)	19 (25)	0
Sex
Male	39 (46.99)	25 (32.90)	5 (41.67)	0.194
Female	44 (53.01)	51 (67.10)	7 (58.33)
Sex (female:male)	1.1:1	2.1:1	1.4:1
Laterality				0.162
Unilateral	68 (81.93)	70 (92.10)	10 (83.33)
Bilateral	15 (18.07)	6 (7.90)	2 (16.67)
Body temp				< 0.01
No fever	29 (34.94)	11 (14.47)	0 (0)
Temp between 37-40 °C	54 (65.06)	58 (76.31)	5 (41.67)
Temp < 36.8 °C, > 40 °C	0	7 (9.21)	7 (58.33)
Level of consciousness				< 0.01
Alert	82 (98.8)	51 (67.10)	4 (33.33)
Disoriented/unconscious	1 (1.2)	25 (32.90)	8 (66.67)
Other parameters
Palpable tender kidney	7 (8.43)	48 (63.16)	12 (100)	< 0.01
Shock at presentation	1 (1.21)	20 (2.63)	11 (91.67)	< 0.01
Need for intensive care unit care	9 (10.84)	43 (56.58)	12 (100)	< 0.01
Need for hemodialysis	5 (5.95)	15 (19.74)	11 (91.67)	< 0.01
Presence of diabetes mellitus	71 (85.6)	73 (96.1)	12 (100)	0.035
Early nephrectomy	0 (0)	2 (2.63)	6 (50)	< 0.01
Mean combined prognostic scoring (SD)	10.74 (3.81)	12.95 (3.90)	21.92 (2.61)	< 0.01
Risk stratification index				< 0.01
1	22 (26.5)	9 (11.84)	0
2	50 (60.24)	46 (60.52)	0
3	11 (13.25)	18 (23.68)	3 (25)
4	0 (0)	3 (3.95)	9 (75)